MedTrace Logo

Evaluation of Molecular Point-of-care Xpert® Xpress SARS-CoV-2 Detection Implementation in Resource-limited Settings

NCT05514886 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3429

Last updated 2024-09-19

No results posted yet for this study

Summary

This study evaluated the diagnostic accuracy and effectiveness of POC viral load (VL) assay in improving the availability of SARS-CoV-2 detection for COVID-19 patient management in decentralised healthcare facilities of resource-constrained settings in Tanzania, DR Congo and Burkina Faso.

Conditions

Interventions

DEVICE

Gene Expert molecular Point-of-Care (POC) (Xpert® Xpress SARS-CoV-2/Flu/RSV test

POC viral load (VL) assay in improving the availability of SARS-CoV-2 detection for COVID-19 patient management in decentralized healthcare facilities of resource-constrained settings in Tanzania, DR Congo and Burkina Faso.

Sponsors & Collaborators

  • University of Kinshasa

    collaborator OTHER

  • Research Institute for Health Sciences - Burkina Faso

    collaborator UNKNOWN

  • Universiteit Antwerpen, Belgium

    collaborator UNKNOWN

  • Københavns Universitet

    collaborator OTHER

  • Universidad de Valencia, Spain

    collaborator UNKNOWN

  • National Institute for Medical Research, Tanzania

    lead OTHER_GOV

Principal Investigators

  • DANIEL TR MINJA, PhD · National Institute for Medical Research, Tanzania

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-10
Primary Completion
2024-02-29
Completion
2024-02-29

Countries

  • Tanzania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05514886 on ClinicalTrials.gov